Skip to main content
. 2016 Mar 15;16:36. doi: 10.1186/s12883-016-0561-z

Table 5.

Adjusteda OR (95 % CI) of TC levels in the outcomes at 3, 12, and 36 months after stroke in acute ischemic stroke patients

Outcomes Group 1 Group 2 Group 3 Group 4 Group 5
3 months:
 Mortality 1.00 0.77 (0.52, 1.13) 0.73 (0.49, 1.08) 1.08 (0.74, 1.55) 0.99 (0.68, 1.44)
 Dependency 1.00 0.98 (0.75, 1.29) 0.84 (0.63, 1.10) 0.88 (0.67, 1.17) 1.04 (0.79, 1.37)
 Recurrence 1.00 0.89 (0.68, 1.18) 0.82 (0.62, 1.09) 0.85 (0.64, 1.13) 1.02 (0.77, 1.35)
12 months:
 Mortality 1.00 0.99 (0.70, 1.39) 0.74 (0.52, 1.07) 1.11 (0.79, 1.57) 1.22 (0.87, 1.71)
 Dependency 1.00 0.86 (0.70, 1.06) 0.83 (0.68, 1.03) 0.92 (0.75, 1.13) 0.87 (0.71, 1.09)
 Recurrence 1.00 0.91 (0.74, 1.11) 0.86 (0.70, 1.05) 0.95 (0.77, 1.16) 0.89 (0.72, 1.10)
36 months:
 Mortality 1.00 1.15 (0.84, 1.58) 0.88 (0.63, 1.23) 1.12 (0.81, 1.56) 1.07 (0.77, 1.49)
 Dependency 1.00 0.79 (0.63, 0.99)a 0.76 (0.60, 0.95)a 0.78 (0.62, 0.99)a 0.71 (0.56, 0.90)a
 Recurrence 1.00 0.86 (0.70, 1.07) 0.80 (0.64, 0.99)a 0.81 (0.64, 1.01) 0.73 (0.58, 0.91)a

TC total cholesterol, OR odds ratios, CI confidence intervals

aAdjusted by sex, age, stroke severity, OCSP, risk factors (hypertension, diabetes, atrial fibrillation, artery stenosis, obesity, current smoking, and alcohol consumption) as covariates